LC-MS/MS based methods can even differentiate between the isobaric LisPro (Humalog) insulin used to treat diabetes and endogenous insulin, due to a signature product ion derived from the transposition of the proline and lysine residue [25]. This evidence concerns the gene INS and diabetes mellitus.